JOP20210313A1 - مشتقات حلقية غير متجانسة مندمجة - Google Patents

مشتقات حلقية غير متجانسة مندمجة

Info

Publication number
JOP20210313A1
JOP20210313A1 JOP/2021/0313A JOP20210313A JOP20210313A1 JO P20210313 A1 JOP20210313 A1 JO P20210313A1 JO P20210313 A JOP20210313 A JO P20210313A JO P20210313 A1 JOP20210313 A1 JO P20210313A1
Authority
JO
Jordan
Prior art keywords
fused heterocyclic
heterocyclic derivatives
compounds
preparing
treatment
Prior art date
Application number
JOP/2021/0313A
Other languages
Arabic (ar)
English (en)
Inventor
Koen Vandyck
Lamenca Carolina Martinez
Serge Maria Aloyssius Pieters
Jan Martin Berke
Tim Hugo Maria Jonckers
Yimin Jiang
Lindsey Graham Deratt
Gang Deng
Pierre Jean-Marie Bernard Raboisson
Yanping Xu
Sandrine Céline Grosse
Wim Gaston Verschueren
Scott D Kuduk
Bart Rudolf Romanie Kesteleyn
Morgan Charles R Lecomte
Lili Hu
Zhanling Cheng
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=71741889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JOP20210313(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of JOP20210313A1 publication Critical patent/JOP20210313A1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JOP/2021/0313A 2019-05-28 2021-11-25 مشتقات حلقية غير متجانسة مندمجة JOP20210313A1 (ar)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962853533P 2019-05-28 2019-05-28
EP19176933 2019-05-28
CN2020085720 2020-04-20
PCT/US2020/034643 WO2020243135A1 (en) 2019-05-28 2020-05-27 Fused heterocyclic derivatives

Publications (1)

Publication Number Publication Date
JOP20210313A1 true JOP20210313A1 (ar) 2021-11-25

Family

ID=71741889

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2021/0313A JOP20210313A1 (ar) 2019-05-28 2021-11-25 مشتقات حلقية غير متجانسة مندمجة

Country Status (19)

Country Link
EP (1) EP3976617B1 (cg-RX-API-DMAC7.html)
JP (1) JP2022535734A (cg-RX-API-DMAC7.html)
KR (1) KR20220012913A (cg-RX-API-DMAC7.html)
CN (1) CN113906028A (cg-RX-API-DMAC7.html)
AU (1) AU2020285718A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021022889A8 (cg-RX-API-DMAC7.html)
CA (1) CA3138168A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021003155A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021016433A2 (cg-RX-API-DMAC7.html)
CR (1) CR20210666A (cg-RX-API-DMAC7.html)
DO (1) DOP2021000230A (cg-RX-API-DMAC7.html)
IL (1) IL288322A (cg-RX-API-DMAC7.html)
JO (1) JOP20210313A1 (cg-RX-API-DMAC7.html)
MA (1) MA56043A (cg-RX-API-DMAC7.html)
MX (1) MX2021014575A (cg-RX-API-DMAC7.html)
PE (1) PE20220767A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021552974A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202113167QA (cg-RX-API-DMAC7.html)
WO (1) WO2020243135A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022116999A1 (en) * 2020-12-02 2022-06-09 Janssen Sciences Ireland Unlimited Company Fused heterocyclic derivatives and their use in the treatment of hbv infection
WO2022116998A1 (en) * 2020-12-02 2022-06-09 Janssen Sciences Ireland Unlimited Company Fused heterocyclic derivatives as hbv inhibitors
TW202237617A (zh) * 2020-12-02 2022-10-01 愛爾蘭商健生科學愛爾蘭無限公司 稠合雜環衍生物
AR126049A1 (es) 2021-06-02 2023-09-06 Janssen Sciences Ireland Unlimited Co Derivados heterocíclicos condensados
CA3218641A1 (en) * 2021-06-02 2022-12-08 Chunliang Lu Fused heterocyclic derivatives
WO2024114709A1 (en) * 2022-12-01 2024-06-06 Janssen Sciences Ireland Unlimited Company A crystal form of a fused heterocycle derivative compound
WO2024140851A1 (zh) * 2022-12-28 2024-07-04 上海维申医药有限公司 一类Toll样受体抑制剂及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2993174A1 (en) * 2014-09-08 2016-03-09 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH Pyrazolopyridine derivatives and their use in therapy
WO2016109689A2 (en) * 2014-12-30 2016-07-07 Novira Therapeutics, Inc. Derivatives and methods of treating hepatitis b infections
CA3029566A1 (en) * 2016-06-29 2018-01-04 Novira Therapeutics, Inc. Diazepinone derivatives and their use in the treatment of hepatitis b infections
TW201806956A (zh) * 2016-06-29 2018-03-01 諾維拉治療公司 二氮呯酮衍生物及治療b型肝炎感染之方法
US20220306647A1 (en) * 2019-04-30 2022-09-29 Aicuris Gmbh & Co. Kg Novel indole-2-carboxamides active against the hepatitus b virus (hbv)

Also Published As

Publication number Publication date
EP3976617B1 (en) 2025-04-23
CL2021003155A1 (es) 2022-07-22
MA56043A (fr) 2022-04-06
MX2021014575A (es) 2022-05-24
WO2020243135A1 (en) 2020-12-03
PH12021552974A1 (en) 2022-07-11
AU2020285718A1 (en) 2022-02-03
CR20210666A (es) 2022-03-11
PE20220767A1 (es) 2022-05-16
EP3976617A1 (en) 2022-04-06
CO2021016433A2 (es) 2021-12-10
BR112021022889A8 (pt) 2024-03-05
DOP2021000230A (es) 2022-05-31
KR20220012913A (ko) 2022-02-04
SG11202113167QA (en) 2021-12-30
CN113906028A (zh) 2022-01-07
BR112021022889A2 (pt) 2022-01-04
CA3138168A1 (en) 2020-12-03
IL288322A (en) 2022-01-01
JP2022535734A (ja) 2022-08-10

Similar Documents

Publication Publication Date Title
PH12021552974A1 (en) Fused heterocyclic derivatives
GEAP202014690A (en) Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
PH12016501394A1 (en) Compounds for treating patients with ros1 mutant cancer cells
PH12019501034A1 (en) New anthelmintic quinoline-3-carboxamide derivatives
ZA202201499B (en) Dual atm and dna-pk inhibitors for use in anti-tumor therapy
PH12020500257A1 (en) Quinoline derivatives for treating infections with helminths
IL286210A (en) Compressed ring pyrimidine history for use in the treatment of hbv infection or diseases caused by hbv
MX391655B (es) Derivado de oxopicolinamida, metodo de preparacion y uso farmaceutico del mismo
MX2022011029A (es) Compuestos de arilo, heteroarilo y heterociclicos para el tratamiento de trastornos medicos.
PH12020551891A1 (en) New quinoline derivatives
CR20190595A (es) Nuevos derivados de azaquinolina
MX2009010059A (es) Derivados de quinolina para el tratamiento de enfermedades inflamatorias.
GEP201606560B (en) Macrocyclic derivatives for the treatment of proliferative diseases
PH12019502365A1 (en) New bicyclic pyrazole derivatives
EA201591541A1 (ru) Ингибиторы бета-секретазы 1 (bace 1)
ZA202003281B (en) Heterocycle substituted pyridine derivative antifungal agents
WO2022116997A8 (en) Fused heterocyclic derivatives and their use in the treatment of hbv infection
MX380301B (es) Prevención o tratamiento de enfermedades urinarias o gotosas.
MX2021014581A (es) Derivados heterociclicos condensados.
MX2021014576A (es) Derivados heterociclicos condensados como agentes antivirales.
LT3759113T (lt) 10-(di(fenil)metil)-4-hidroksi-8,9,9a,10-tetrahidro-7h-pirolo[1',2':4,5] pirazino[1,2-b]piridazin-3,5-diono dariniai ir susiję junginiai kaip ortomiksoviruso replikacijos inhibitoriai, skirti gripo gydymui
SG11201901617PA (en) Azole compound ophthalmic preparation
MX2022006489A (es) Derivado de anillo de piridina fusionado, metodo de preparacion y usos farmaceuticos del mismo.
WO2020055368A3 (en) Use of terpernic coumarin derivatives for use in treating viral diseases
ECSP21092791A (es) Derivados heterocíclicos condensados